{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:13:10Z","timestamp":1755216790313,"version":"3.43.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>The role of cortactin in T-cell acute lymphoblastic leukemia (T-ALL) tissue infiltration has been previously reported. However, its impact on patients\u2019 responsiveness to therapy and patient\u2019s outcome was not previously addressed. This study was conducted on 60 T-ALL pediatric patients at diagnosis and 10 nonleukemic controls. Cortactin and HS1 expressions were identified by real-time polymerase chain reaction. Cortactin and HS1 expression were significantly higher in T-All patients as compared with controls as well as postinduction levels (<jats:italic toggle=\"yes\">P<\/jats:italic>\u22640.001 for both). The high cortactin expression was significantly associated with high peripheral white cell counts (<jats:italic toggle=\"yes\">P<\/jats:italic>\u22640.001), blood blast cells (<jats:italic toggle=\"yes\">P<\/jats:italic>\u22640.001) and central nervous system (CNS) infiltration (<jats:italic toggle=\"yes\">P<\/jats:italic>\u22640.001), and early precursor T-ALL subtype (<jats:italic toggle=\"yes\">P<\/jats:italic>\u22640.001) as compared with the remaining groups. The induction of remission response was significantly higher in T-ALL patients with lower cortactin expression levels as compared with T-ALL patients with higher one (<jats:italic toggle=\"yes\">P<\/jats:italic>\u22640.001). The high cortactin and HS1 expressions were significantly predictors of CNS infiltrations (hazard ratios [HR]: 1.051, confidence interval [CI]: 1.02-1.13, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.04 and HR: 1.87, CI: 1.23-2.091, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.002, respectively) and bone marrow relapse (HR: 1.43, CI: 1.18-1.92, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.004 and HR: 1.07, CI: 1.01-1.24, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.002, respectively). Furthermore, high cortactin expression levels were associated with shorter B-ALL patients\u2019 overall survival as compared with those with lower cortactin levels (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.002). In conclusion, high expression of cortactin and\/or HS1 at diagnosis is a bad prognostic marker of T-ALL patients\u2019 outcome. Moreover, cortactin and\/or HS1 expression could be used as a biomarker for refining risk stratification of T-ALL.<\/jats:p>","DOI":"10.1097\/mph.0000000000002010","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T19:04:57Z","timestamp":1606244697000},"page":"e798-e803","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Cortactin Expression is a Novel Biomarker for Risk Stratification of T-Cell Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"43","author":[{"given":"Salah","family":"Aref","sequence":"first","affiliation":[{"name":"Haematology Unit, Mansoura University Oncology Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enas","family":"Fawzy","sequence":"additional","affiliation":[{"name":"Haematology Unit, Mansoura University Oncology Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Darwish","sequence":"additional","affiliation":[{"name":"Paediatric Department, Paediatric Haematology Oncology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Aref","sequence":"additional","affiliation":[{"name":"Mansoura Faculty of Medicine, Mansoura University, Mansoura, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Al","family":"Agdar","sequence":"additional","affiliation":[{"name":"Haematology Unit, Mansoura University Oncology Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3324\/haematol.2008.004150","article-title":"T-cell acute lymphoblastic leukemia","volume":"94","author":"Chiaretti","year":"2009","journal-title":"Haematologica"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ajpath.2019.12.011","article-title":"Cortactin expression in hematopoietic cells implications for hematological malignancies","volume":"190","author":"Castellanos-Mart\u00ednez","year":"2020","journal-title":"Am J Pathol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3324\/haematol.2013.090183","article-title":"Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia","volume":"99","author":"Gattazzo","year":"2014","journal-title":"Haematologica"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tcb.2017.10.009","article-title":"Cortactin: cell functions of a multifaceted actin-binding protein","volume":"28","author":"Schnoor","year":"2018","journal-title":"Trends Cell Biol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/cm.20296","article-title":"Cortactin branches out: roles in regulating protrusive actin dynamics","volume":"65","author":"Ammer","year":"2008","journal-title":"Cell Motil Cytoskeleton"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1242\/jcs.093781","article-title":"Cortactin in cell migration and cancer at a glance","volume":"125","author":"MacGrath","year":"2012","journal-title":"J Cell Sci"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.blre.2017.08.006","article-title":"T cell acute lymphoblastic leukemia (T-ALL): new insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies","volume":"32","author":"Vadillo","year":"2018","journal-title":"Blood Rev"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11033-016-3972-4","article-title":"Cortactin and Exo70 mediated invasion of hepatoma carcinoma cells byMMP-9 secretion","volume":"43","author":"Gang","year":"2016","journal-title":"Mol Biol Rep"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12935-019-0798-x","article-title":"Overexpression and Tyr421- phosphorylation of cortactin is induced by three-dimensional spheroid culturing and contributes to migration and invasion of pancreatic ductal adenocarcinoma (PDAC) cells","volume":"19","author":"Stock","year":"2019","journal-title":"Cancer Cell Int"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1080\/10428190802517732","article-title":"Augmented and standard Berlin-Frankfurt-M\u00fcnster chemotherapy for treatment of adult acute lymphoblastic leukemia","volume":"49","author":"Chang","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41375-018-0333-4","article-title":"High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse","volume":"33","author":"Vel\u00e1zquez-Avila","year":"2019","journal-title":"Leukemia"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"32609","DOI":"10.18632\/oncotarget.25975","article-title":"Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells","volume":"9","author":"Koya","year":"2018","journal-title":"Oncotarget"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"88232","DOI":"10.18632\/oncotarget.21088","article-title":"Cortactin in cancer cell migration and invasion","volume":"8","author":"Yin","year":"2017","journal-title":"Oncotarget"},{"article-title":"New protein markers of chronic lymphocytic and acute lymphocytic leukemia, advances in hematologic malignancies, Gamal Abdul Hamid, IntechOpen","year":"2019","author":"Mad\u2019arov\u00e1","key":"R15-20250804"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1186\/s12943-019-0983-5","article-title":"Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review","volume":"18","author":"Peltanova","year":"2019","journal-title":"Mol Cancer"},{"issue":"suppl","key":"R17-20250804","first-page":"368","article-title":"The actin-binding protein cortactin controls trans endothelial migration and organ infiltration of acute lymphoblastic leukemia T-cells. The Federation of American Societies for Experimental Biology","volume":"33","author":"Castellanos-Mart\u00ednez","year":"2019","journal-title":"FASEB J"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1084\/jem.20101920","article-title":"Cortactin deficiency is associated with reduced neutrophil recruitment but increased vascular permeability in vivo","volume":"208","author":"Schnoor","year":"2011","journal-title":"J Exp Med"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","article-title":"Relapsed childhood acute lymphoblastic leukaemia","volume":"14","author":"Bhojwani","year":"2013","journal-title":"Lancet Oncol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ccell.2016.11.002","article-title":"Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia","volume":"30","author":"Ebinger","year":"2016","journal-title":"Cancer Cell"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ccr.2014.04.015","article-title":"Leukemia propagating cells rebuild an evolving niche in response to therapy","volume":"25","author":"Duan","year":"2014","journal-title":"Cancer Cell"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3892\/or.2016.5058","article-title":"Cortactin promotes cell migration and invasion through upregulation of the dedicator of cytokinesis 1 expression in human colorectal cancer","volume":"36","author":"Jing","year":"2016","journal-title":"Oncol Rep"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00666","article-title":"Pro-inflammatory-related loss of CXCL12 niche promotes acute lymphoblastic leukemic progression at the expense of normal lymphopoiesis","volume":"7","author":"Balandr\u00e1n","year":"2017","journal-title":"Front Immunol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ccell.2015.05.003","article-title":"CXCR4 is required for leukemia-initiating cell activity in T cell acute lymphoblastic leukemia","volume":"27","author":"Passaro","year":"2015","journal-title":"Cancer Cell"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.cub.2011.06.065","article-title":"Cortactin controls cell motility and lamellipodial dynamics by regulating ECM secretion","volume":"21","author":"Sung","year":"2011","journal-title":"Curr Biol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:10:44Z","timestamp":1754338244000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002010","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"2020-05-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}